Viewing Study NCT01371604


Ignite Creation Date: 2025-12-24 @ 9:15 PM
Ignite Modification Date: 2026-01-05 @ 2:29 AM
Study NCT ID: NCT01371604
Status: COMPLETED
Last Update Posted: 2015-02-06
First Post: 2011-06-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks (MK-2355-005)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module